Lin Tao
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Lin Tao has a total of 120 co-authors. Here are the top co-authors by number of shared publications:
- Feng Zhu
Zhejiang University
11 shared publications - Tian Xie
School of Pharmacy, Hangzhou Normal University, Hangzhou 311121, China
9 shared publications Hongquan Xu
School of Pharmaceutical Sciences, Sun Yat-sen University , Guangzhou 510006
8 shared publicationsHong-Quan Xu
School of Pharmaceutical Sciences
7 shared publicationsYuhong Liu
Key Laboratory of Elemene Class Anti-Cancer Chinese Medicines, School of Pharmacy, Hangzhou Normal University , Hangzhou 311121
7 shared publicationsSisi Zhu
Key Laboratory of Elemene Class Anti-Cancer Chinese Medicines, School of Pharmacy, Hangzhou Normal University, Hangzhou 311121, China
6 shared publications
Latest Publications
- 10 January 2026
- Published by Elsevier in Journal of Molecular Biology
- Vol. 438 (18) , 169633
CovInter 2.0: Comprehensive Molecular Interactome of Coronavirus Infection
- 10 January 2026
- Published by Elsevier in Journal of Molecular Biology
- Vol. 438 (18) , 169633
CovInter 2.0: Comprehensive Molecular Interactome of Coronavirus Infection
- Open Access
- 9 January 2026
- Published by Oxford University Press (OUP) in Briefings in Functional Genomics
- Vol. 25
An integrative meta-analysis of SARS-CoV-2 RNA–protein interactomes identifies conserved host factors shared with other RNA viruses
RNA viruses cause substantial global disease burden and depend on host RNA-binding proteins and translation machinery. However, it remains unclear which host factors are robustly engaged across independent Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) RNA interactome studies and to what extent these factors are shared with other RNA viruses. Here, we perform an integrative meta-analysis of eight published SARS-CoV-2 RNA–protein interactomes and compare them with corresponding Influenza A virus, Zika virus, and Dengue virus datasets to define conserved host networks and prioritize candidate host-directed antiviral targets. By integrating multiple datasets and applying ClusterProfiler together with curated pathway resources (KEGG, Reactome, WikiPathways, and Gene Ontology), we systematically characterize the functional landscape of SARS-CoV-2 RNA–protein interactions. The consensus SARS-CoV-2 interactome is enriched for mRNA processing, translation, RNA surveillance and innate immune functions. Cross-viral comparison identifies 275 host proteins shared across all four RNA viruses, forming interconnected modules that include key translation factors (EEF1A1, EIF4A1, EIF3H) and RNA-binding proteins (Nucleolin, ILF3). Drug–target annotation prioritizes 21 proteins with 35 approved or investigational modulators for host-directed antiviral repurposing. Together, these findings generate a consensus map of conserved host dependencies and highlight prioritized targets for future mechanistic and translational studies. Research Highlights Integrated SARS-CoV-2 datasets and compared with, Influenza A virus, Zika virus, Dengue virus. Identified 275 host proteins shared across these four pathogens. Conserved proteins were enriched in translation, RNA processing, and innate immune pathways. Prioritized 21 host targets and 35 drugs for antiviral repurposing.
- 9 January 2026
- Published by Oxford University Press (OUP) in Briefings in Functional Genomics
- Vol. 25
Open AccessAn integrative meta-analysis of SARS-CoV-2 RNA–protein interactomes identifies conserved host factors shared with other RNA viruses
RNA viruses cause substantial global disease burden and depend on host RNA-binding proteins and translation machinery. However, it remains unclear which host factors are robustly engaged across independent Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) RNA interactome studies and to what extent these factors are shared with other RNA viruses. Here, we perform an integrative meta-analysis of eight published SARS-CoV-2 RNA–protein interactomes and compare them with corresponding Influenza A virus, Zika virus, and Dengue virus datasets to define conserved host networks and prioritize candidate host-directed antiviral targets. By integrating multiple datasets and applying ClusterProfiler together with curated pathway resources (KEGG, Reactome, WikiPathways, and Gene Ontology), we systematically characterize the functional landscape of SARS-CoV-2 RNA–protein interactions. The consensus SARS-CoV-2 interactome is enriched for mRNA processing, translation, RNA surveillance and innate immune functions. Cross-viral comparison identifies 275 host proteins shared across all four RNA viruses, forming interconnected modules that include key translation factors (EEF1A1, EIF4A1, EIF3H) and RNA-binding proteins (Nucleolin, ILF3). Drug–target annotation prioritizes 21 proteins with 35 approved or investigational modulators for host-directed antiviral repurposing. Together, these findings generate a consensus map of conserved host dependencies and highlight prioritized targets for future mechanistic and translational studies. Research Highlights Integrated SARS-CoV-2 datasets and compared with, Influenza A virus, Zika virus, Dengue virus. Identified 275 host proteins shared across these four pathogens. Conserved proteins were enriched in translation, RNA processing, and innate immune pathways. Prioritized 21 host targets and 35 drugs for antiviral repurposing.
- Open Access
- 28 November 2025
- Published by Oxford University Press (OUP) in Nucleic Acids Research
- Vol. 54 (D1) , D607-D616
MetabFlow: a comprehensive metabolic map for exogenous natural products
Exogenous natural products (NPs) undergo complex metabolic transformations both in vivo and in vitro, generating structurally diverse metabolites. Due to the involvement of host enzymes and gut microbiota, as well as the structural complexity of NPs themselves, their metabolic processes exhibit unique characteristics. However, existing metabolic transformation information remains fragmented, limiting systematic understanding of their metabolic mechanisms. To address this gap, MetabFlow (https://bddg.hznu.edu.cn/metabflow/), a comprehensive database dedicated to the metabolism of exogenous NPs, was developed. MetabFlow is distinguished by: (a) systematic integration of 7294 curated metabolic reactions covering both in vivo and in vitro transformations, providing a complete knowledge map of exogenous NP metabolism; (b) unique integration of enzyme-catalyzed and microbiota-mediated reactions, highlighting the distinctive metabolic features of NPs; (c) establishment of a structured metabolic network by constructing upstream-downstream reaction relationships, elucidating how exogenous NPs evolve across different metabolic pathways; (d) inclusion of approximately 3200 compounds not indexed in mainstream databases, with detailed structural information, annotations, and complete metabolic profiles. MetabFlow is designed to support research in NP metabolism, drug discovery, and related fields.
- 28 November 2025
- Published by Oxford University Press (OUP) in Nucleic Acids Research
- Vol. 54 (D1) , D607-D616
Open AccessMetabFlow: a comprehensive metabolic map for exogenous natural products
Exogenous natural products (NPs) undergo complex metabolic transformations both in vivo and in vitro, generating structurally diverse metabolites. Due to the involvement of host enzymes and gut microbiota, as well as the structural complexity of NPs themselves, their metabolic processes exhibit unique characteristics. However, existing metabolic transformation information remains fragmented, limiting systematic understanding of their metabolic mechanisms. To address this gap, MetabFlow (https://bddg.hznu.edu.cn/metabflow/), a comprehensive database dedicated to the metabolism of exogenous NPs, was developed. MetabFlow is distinguished by: (a) systematic integration of 7294 curated metabolic reactions covering both in vivo and in vitro transformations, providing a complete knowledge map of exogenous NP metabolism; (b) unique integration of enzyme-catalyzed and microbiota-mediated reactions, highlighting the distinctive metabolic features of NPs; (c) establishment of a structured metabolic network by constructing upstream-downstream reaction relationships, elucidating how exogenous NPs evolve across different metabolic pathways; (d) inclusion of approximately 3200 compounds not indexed in mainstream databases, with detailed structural information, annotations, and complete metabolic profiles. MetabFlow is designed to support research in NP metabolism, drug discovery, and related fields.
- 10 March 2025
- Published by American Chemical Society (ACS) in Journal of Chemical Information and Modeling
- Vol. 65 (6) , 2722-2729
ASVirus: A Comprehensive Knowledgebase for the Viral Alternative Splicing
Viruses are significant human pathogens responsible for pandemic outbreaks and seasonal epidemics. Viral infectious diseases impose a devastating global burden and have a profound impact on public health systems. During viral infections, alternative splicing (AS) plays a crucial role in regulating immune responses, altering the host's cellular environment, expanding viral genetic material, and facilitating viral replication. As research on AS in viral infections expands, it is crucial to consolidate data on virus-related splicing changes to improve our understanding of these viruses and associated diseases. To address this need, we created ASVirus (https://bddg.hznu.edu.cn/asvirus/), a comprehensive database of virus-associated AS events and their regulatory factors. ASVirus uniquely combines high-confidence, experimentally validated splicing data and investigates upstream regulatory mechanisms through a gene-splicing factor interaction network. Its user-friendly web interface offers detailed information into AS events from various viral families and the resulting mis-splicing in host genes, aiding the exploration of novel viral infection mechanisms and the identification of critical therapeutic targets for viral diseases.
- 10 March 2025
- Published by American Chemical Society (ACS) in Journal of Chemical Information and Modeling
- Vol. 65 (6) , 2722-2729
ASVirus: A Comprehensive Knowledgebase for the Viral Alternative Splicing
Viruses are significant human pathogens responsible for pandemic outbreaks and seasonal epidemics. Viral infectious diseases impose a devastating global burden and have a profound impact on public health systems. During viral infections, alternative splicing (AS) plays a crucial role in regulating immune responses, altering the host's cellular environment, expanding viral genetic material, and facilitating viral replication. As research on AS in viral infections expands, it is crucial to consolidate data on virus-related splicing changes to improve our understanding of these viruses and associated diseases. To address this need, we created ASVirus (https://bddg.hznu.edu.cn/asvirus/), a comprehensive database of virus-associated AS events and their regulatory factors. ASVirus uniquely combines high-confidence, experimentally validated splicing data and investigates upstream regulatory mechanisms through a gene-splicing factor interaction network. Its user-friendly web interface offers detailed information into AS events from various viral families and the resulting mis-splicing in host genes, aiding the exploration of novel viral infection mechanisms and the identification of critical therapeutic targets for viral diseases.
- Top Cited Papers
- 7 February 2025
- Published by Elsevier in Biotechnology Advances
- Vol. 79, 108532
Computational advances in biosynthetic gene cluster discovery and prediction
- 7 February 2025
- Published by Elsevier in Biotechnology Advances
- Vol. 79, 108532
Top Cited PapersComputational advances in biosynthetic gene cluster discovery and prediction
- Open Access
- 4 December 2024
- Published by Elsevier in Journal of Pharmaceutical Analysis
- Vol. 15 (8) , 101157
The integration of machine learning into traditional Chinese medicine
- 4 December 2024
- Published by Elsevier in Journal of Pharmaceutical Analysis
- Vol. 15 (8) , 101157
Open AccessThe integration of machine learning into traditional Chinese medicine
- Open Access
- 7 October 2024
- Published by Oxford University Press (OUP) in Nucleic Acids Research
- Vol. 53 (D1) , D504-D515
OrgXenomics: an integrated proteomic knowledge base for patient-derived organoid and xenograft
Patient-derived models (PDMs, particularly organoids and xenografts) are irreplaceable tools for precision medicine, from target development to lead identification, then to preclinical evaluation, and finally to clinical decision-making. So far, PDM-based proteomics has emerged to be one of the cutting-edge directions and massive data have been accumulated. However, such PDM-based proteomic data have not been provided by any of the available databases, and proteomics profiles of all proteins in proteomic study are also completely absent from existing databases. Herein, an integrated database named ‘OrgXenomics’ was thus developed to provide the proteomic data for PDMs, which was unique in (a) explicitly describing the establishment detail for a wide array of models, (b) systematically providing the proteomic profiles (expression/function/interaction) for all proteins in studied proteomic analysis and (c) comprehensively giving the raw data for diverse organoid/xenograft-based proteomic studies of various diseases. Our OrgXenomics was expected to server as one good complement to existing proteomic databases, and had great implication for the practice of precision medicine, which could be accessed at: https://idrblab.org/orgxenomics/
- 7 October 2024
- Published by Oxford University Press (OUP) in Nucleic Acids Research
- Vol. 53 (D1) , D504-D515
Open AccessOrgXenomics: an integrated proteomic knowledge base for patient-derived organoid and xenograft
Patient-derived models (PDMs, particularly organoids and xenografts) are irreplaceable tools for precision medicine, from target development to lead identification, then to preclinical evaluation, and finally to clinical decision-making. So far, PDM-based proteomics has emerged to be one of the cutting-edge directions and massive data have been accumulated. However, such PDM-based proteomic data have not been provided by any of the available databases, and proteomics profiles of all proteins in proteomic study are also completely absent from existing databases. Herein, an integrated database named ‘OrgXenomics’ was thus developed to provide the proteomic data for PDMs, which was unique in (a) explicitly describing the establishment detail for a wide array of models, (b) systematically providing the proteomic profiles (expression/function/interaction) for all proteins in studied proteomic analysis and (c) comprehensively giving the raw data for diverse organoid/xenograft-based proteomic studies of various diseases. Our OrgXenomics was expected to server as one good complement to existing proteomic databases, and had great implication for the practice of precision medicine, which could be accessed at: https://idrblab.org/orgxenomics/
- Open Access
- 27 March 2024
- Published by Oxford University Press (OUP) in Briefings in Bioinformatics
- Vol. 25 (3)
DDID: a comprehensive resource for visualization and analysis of diet–drug interactions
Diet–drug interactions (DDIs) are pivotal in drug discovery and pharmacovigilance. DDIs can modify the systemic bioavailability/pharmacokinetics of drugs, posing a threat to public health and patient safety. Therefore, it is crucial to establish a platform to reveal the correlation between diets and drugs. Accordingly, we have established a publicly accessible online platform, known as Diet-Drug Interactions Database (DDID, https://bddg.hznu.edu.cn/ddid/), to systematically detail the correlation and corresponding mechanisms of DDIs. The platform comprises 1338 foods/herbs, encompassing flora and fauna, alongside 1516 widely used drugs and 23 950 interaction records. All interactions are meticulously scrutinized and segmented into five categories, thereby resulting in evaluations (positive, negative, no effect, harmful and possible). Besides, cross-linkages between foods/herbs, drugs and other databases are furnished. In conclusion, DDID is a useful resource for comprehending the correlation between foods, herbs and drugs and holds a promise to enhance drug utilization and research on drug combinations.
- 27 March 2024
- Published by Oxford University Press (OUP) in Briefings in Bioinformatics
- Vol. 25 (3)
Open AccessDDID: a comprehensive resource for visualization and analysis of diet–drug interactions
Diet–drug interactions (DDIs) are pivotal in drug discovery and pharmacovigilance. DDIs can modify the systemic bioavailability/pharmacokinetics of drugs, posing a threat to public health and patient safety. Therefore, it is crucial to establish a platform to reveal the correlation between diets and drugs. Accordingly, we have established a publicly accessible online platform, known as Diet-Drug Interactions Database (DDID, https://bddg.hznu.edu.cn/ddid/), to systematically detail the correlation and corresponding mechanisms of DDIs. The platform comprises 1338 foods/herbs, encompassing flora and fauna, alongside 1516 widely used drugs and 23 950 interaction records. All interactions are meticulously scrutinized and segmented into five categories, thereby resulting in evaluations (positive, negative, no effect, harmful and possible). Besides, cross-linkages between foods/herbs, drugs and other databases are furnished. In conclusion, DDID is a useful resource for comprehending the correlation between foods, herbs and drugs and holds a promise to enhance drug utilization and research on drug combinations.
- 19 February 2024
- Published by American Chemical Society (ACS) in Journal of Chemical Information and Modeling
- Vol. 64 (7) , 2720-2732
MOINER: A Novel Multiomics Early Integration Framework for Biomedical Classification and Biomarker Discovery
In the context of precision medicine, multiomics data integration provides a comprehensive understanding of underlying biological processes and is critical for disease diagnosis and biomarker discovery. One commonly used integration method is early integration through concatenation of multiple dimensionally reduced omics matrices due to its simplicity and ease of implementation. However, this approach is seriously limited by information loss and lack of latent feature interaction. Herein, a novel multiomics early integration framework (MOINER) based on information enhancement and image representation learning is thus presented to address the challenges. MOINER employs the self-attention mechanism to capture the intrinsic correlations of omics-features, which make it significantly outperform the existing state-of-the-art methods for multiomics data integration. Moreover, visualizing the attention embedding and identifying potential biomarkers offer interpretable insights into the prediction results. All source codes and model for MOINER are freely available https://github.com/idrblab/MOINER.
- 19 February 2024
- Published by American Chemical Society (ACS) in Journal of Chemical Information and Modeling
- Vol. 64 (7) , 2720-2732
MOINER: A Novel Multiomics Early Integration Framework for Biomedical Classification and Biomarker Discovery
In the context of precision medicine, multiomics data integration provides a comprehensive understanding of underlying biological processes and is critical for disease diagnosis and biomarker discovery. One commonly used integration method is early integration through concatenation of multiple dimensionally reduced omics matrices due to its simplicity and ease of implementation. However, this approach is seriously limited by information loss and lack of latent feature interaction. Herein, a novel multiomics early integration framework (MOINER) based on information enhancement and image representation learning is thus presented to address the challenges. MOINER employs the self-attention mechanism to capture the intrinsic correlations of omics-features, which make it significantly outperform the existing state-of-the-art methods for multiomics data integration. Moreover, visualizing the attention embedding and identifying potential biomarkers offer interpretable insights into the prediction results. All source codes and model for MOINER are freely available https://github.com/idrblab/MOINER.
- 20 December 2023
- Published by Elsevier in Computers in Biology and Medicine
- Vol. 169, 107886
RVvictor: Virus RNA-directed molecular interactions for RNA virus infection
- 20 December 2023
- Published by Elsevier in Computers in Biology and Medicine
- Vol. 169, 107886
RVvictor: Virus RNA-directed molecular interactions for RNA virus infection